Contact Us

Contact Us

Please contact us below with any questions

+44 (0)33 3321 2371

Side Contact
COVID-19 Rapid Antigen Lateral Flow Tests in Stock in UK and Available to Buy - More Info
quadratech Logo
{{ toggleHam ? 'CLOSE' : 'MENU' }}
Next Day & International Delivery
Competitive Pricing
Knowledgeable Sales Team
Based In The UK

Update on Potential New Anticoagulants –

The global anticoagulant market is projected to be worth more than $11.2bn by 2015, more than half of this market being for stroke prevention in patients with non-valvular atrial fibrillation (AF).

Unfractionated heparin (UFH) is an injectable anticoagulant that is widely used when rapid anticoagulation is required. UFH binds to antithrombin III and the resulting complex inactivates a number of coagulation proteins, including thrombin (IIa) and factor Xa. This non-specific binding of UFH results in unpredictable efficacy.

The injectable route restricts the use of UFH to a limited timeframe in hospitalised patients, with a need for frequent monitoring of bleeding parameters. Furthermore, heparin-induced thrombocytopenia (HIT) occurs in about 3 per cent of patients receiving UFH.

“The huge market potential, combined with the significant shortcomings of heparins and warfarin, drives development of new anticoagulants…”

Cookie Consent

Cookies help us deliver our services. By using our services, you agree to our use of cookies.